Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för melphalan. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

12 träffar

Bibliografisk träff 2008-07-01

Chromosome aberrations and telomere length modulation in bone marrow and spleen cells of melphalan-treated p53+/- mice.

Sgura A, De Amicis A, Stronati L, Cinelli S, Pacchierotti F, Tanzarella C.

Environ Mol Mutagen · research support, non-u.s. gov't; journal article · DOI 10.1002/em.20405

Bibliografisk träff 2002-01-30

Covalent binding of nitrogen mustards to the cysteine-34 residue in human serum albumin.

Noort D, Hulst AG, Jansen R.

Arch Toxicol · research support, non-u.s. gov't; journal article · DOI 10.1007/s00204-001-0318-2

Bibliografisk träff 2001-09-01

Cytotoxicity and effect on collagen biosynthesis of proline analogue of melphalan as a prolidase-convertible prodrug in cultured human skin fibroblasts.

Chrzanowski K, Bielawska A, Bielawski K, Wołczyński S, Pałka J.

Farmaco · journal article · DOI 10.1016/s0014-827x(01)01130-2

Bibliografisk träff 2000-08-01

Phenyl sulfur mustard derivatives of distamycin A.

Cozzi P, Beria I, Caldarelli M, Capolongo L, Geroni C, Mazzini S, Ragg E.

Bioorg Med Chem Lett · journal article · DOI 10.1016/s0960-894x(00)00295-x

Bibliografisk träff 2000-01-01

Enhanced cytogenetic and antitumor effects by 9-nitrocamptothecin and antineoplastics.

Karaberis E, Mourelatos D.

Teratog Carcinog Mutagen · journal article · DOI 10.1002/(sici)1520-6866(2000)20:3<141::aid-tcm5>3.0.co;2-d

Bibliografisk träff 1997-05-01

Evaluation of the porphyrinogenic risk of antineoplastics.

Cochón AC, Aldonatti C, San Martín de Viale LC, Wainstok de Calmanovici R.

J Appl Toxicol · research support, non-u.s. gov't; journal article · DOI 10.1002/(sici)1099-1263(199705)17:3<171::aid-jat419>3.0.co;2-a

Bibliografisk träff 1997-01-01

Cytotoxic activity of cyclosporin A and [3-keto-Bmt1]-[Val2]-cyclosporin (SDZ PSC 833) on tumour cells from patients with haematological malignancies.

Martinsson P, Nygren P, Fridborg H, Nilsson K, Kristensen J, Larsson R.

Eur J Clin Pharmacol · journal article · DOI 10.1007/s002280050274

Bibliografisk träff 1996-12-01

Kinetics of the reaction of a potential chemopreventive agent, 2,6-dithiopurine, and its major metabolite, 2,6-dithiouric acid, with multiple classes of electrophilic toxicants.

Qing WG, Powell KL, MacLeod MC.

Chem Res Toxicol · research support, non-u.s. gov't; journal article · DOI 10.1021/tx960088n

Bibliografisk träff 1995-12-01

Dominant lethal and heritable translocation tests with chlorambucil and melphalan in male mice.

Generoso WM, Witt KL, Cain KT, Hughes L, Cacheiro NL, Lockhart AM, Shelby MD.

Mutat Res · journal article · DOI 10.1016/0165-1218(95)90052-7

Bibliografisk träff 1995-07-01

Characterization of alkylating versus intercalating anticancer drug-induced effects on cell survival, cell cycle kinetic and morphonuclear pattern of three neoplastic cells lines growing in vitro.

Pauwels O, Kiss R, Pasteels JL, Atassi G.

Pharm Res · research support, non-u.s. gov't; journal article · DOI 10.1023/a:1016258431063

Bibliografisk träff 1995-06-01

Effect of alkyl-N-purine DNA glycosylase overexpression on cellular resistance to bifunctional alkylating agents.

Bramson J, O'Connor T, Panasci L.

Biochem Pharmacol · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1016/0006-2952(95)00114-f

Bibliografisk träff 1979-05-01

Lymphocyte transformation studies in drug hypersensitivity.

Warrington RJ, Tse KS.

Can Med Assoc J · research-article; journal article